REVIA (NALTREXONE HYDROCHLORIDE) — FDA Approval NDA018932 (TEVA WOMENS)
REVIA (NALTREXONE HYDROCHLORIDE) — FDA Approval NDA018932 (TEVA WOMENS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: REVIA; Active ingredients: NALTREXONE HYDROCHLORIDE; Application number: NDA018932.
| Brand name | REVIA |
|---|---|
| Active ingredients | NALTREXONE HYDROCHLORIDE |
| Application number | NDA018932 |
| Sponsor | TEVA WOMENS |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19841120 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →